That's another fluff PR, again unknown valuation source , no breakdown and no domestic interest. It's also NGIO related (class B shares) and little benefit to Class A. GNBT listing no priority ......too many outstanding shares but convenient ATM......no outside funding or interest.......at least it appears that way. Loooongs are on hold ..........
I continue to be skeptical of near-term value . DJ in charge of financial picture due to miscalculated finances......... the key is to protect Class B shareholders .......period !!!
(2)
(2)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links